These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27925847)

  • 21. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
    Sartori AM; de Soárez PC; Novaes HM; Amaku M; de Azevedo RS; Moreira RC; Pereira LM; Ximenes RA; Martelli CM
    Vaccine; 2012 Dec; 30(52):7489-97. PubMed ID: 23107593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted.
    Ellis A; Rüttimann RW; Jacobs RJ; Meyerhoff AS; Innis BL
    Rev Panam Salud Publica; 2007 Jun; 21(6):345-56. PubMed ID: 17761046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.
    Barkai G; Belmaker I; Givon-Lavi N; Dagan R
    Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
    Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.
    Navas E; Salleras L; Gisbert R; Dominguez A; Bruguera M; Rodríguez G; Galí N; Prat A
    Vaccine; 2005 Mar; 23(17-18):2185-9. PubMed ID: 15755592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cost-utility analysis on universal childhood hepatitis A vaccination in regions with different anti-HAV prevalence rates of China].
    Pan XJ; Feng YM; Zhuang GH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):862-6. PubMed ID: 22967346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost-effectiveness of two strategies for vaccinating US veterans with hepatitis C virus infection against hepatitis A and hepatitis B viruses.
    Jakiche R; Borrego ME; Raisch DW; Gupchup GV; Pai MA; Jakiche A
    Am J Med Sci; 2007 Jan; 333(1):26-34. PubMed ID: 17220691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children.
    Hankin-Wei A; Rein DB; Hernandez-Romieu A; Kennedy MJ; Bulkow L; Rosenberg E; Trigg M; Nelson NP
    Vaccine; 2016 Jul; 34(35):4243-4249. PubMed ID: 27317459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brief Report: Response to Hepatitis A Virus Vaccine in HIV-Infected Patients Within a Retrospective, Multicentric Cohort: Facing Hepatitis A Outbreaks in the Clinical Practice.
    Neukam K; Delgado Fernández M; Hernández Quero J; Rivero-Juárez A; Llaves-Flores S; Jiménez Oñate F; Gutiérrez-Valencia A; Espinosa N; Viciana P; López-Cortés LF
    J Acquir Immune Defic Syndr; 2019 May; 81(1):e1-e5. PubMed ID: 30865187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A
    Hepatology; 1999 Feb; 29(2):548-52. PubMed ID: 9918934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-utility analysis of hepatitis A prevention among health-care workers in Israel.
    Chodick G; Lerman Y; Wood F; Aloni H; Peled T; Ashkenazi S
    J Occup Environ Med; 2002 Feb; 44(2):109-15. PubMed ID: 11851212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.
    Nelson NP; Weng MK; Hofmeister MG; Moore KL; Doshani M; Kamili S; Koneru A; Haber P; Hagan L; Romero JR; Schillie S; Harris AM
    MMWR Recomm Rep; 2020 Jul; 69(5):1-38. PubMed ID: 32614811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploration of cost effectiveness of active vaccination in the control of a school outbreak of hepatitis A in a deprived community in the United Kingdom.
    Taylor-Robinson DC; Regan M; Crowcroft N; Parry JV; Dardamissis E
    Euro Surveill; 2007 Dec; 12(12):E5-6. PubMed ID: 18076861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initiation and completion rates of inactivated hepatitis A vaccination among children born between 2005 and 2014 in Zhejiang province, east China.
    Hu Y; Chen Y; Hui L; Wang Y
    Hum Vaccin Immunother; 2018 Apr; 14(4):1013-1017. PubMed ID: 29173014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of a publicly funded hepatitis A travel vaccination program in Ontario, Canada.
    Ramsay LC; Anyiwe K; Li M; Macdonald L; Coyte PC; Sander B
    Vaccine; 2019 Mar; 37(11):1467-1475. PubMed ID: 30770225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic evaluations of hepatitis A vaccination in middle-income countries.
    Suwantika AA; Yegenoglu S; Riewpaiboon A; Tu HA; Postma MJ
    Expert Rev Vaccines; 2013 Dec; 12(12):1479-94. PubMed ID: 24168129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach.
    Dhankhar P; Nwankwo C; Pillsbury M; Lauschke A; Goveia MG; Acosta CJ; Elbasha EH
    Value Health; 2015 Jun; 18(4):358-67. PubMed ID: 26091589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
    Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.